2019 | | A two-photon ratiometric probe for hydrogen polysulfide (H2Sn): Increase in mitochondrial H2Sn production in a Parkinson’s disease model | 박상면 |
2021 | | Age-related increase in caveolin-1 expression facilitates cell-to-cell transmission of α-synuclein in neurons | 박상면, 하태영 |
2024 | | Artificial intelligence-driven drug repositioning uncovers efavirenz as a modulator of α-synuclein propagation: Implications in Parkinson's disease | 김동규, 김수정, 박상면, 우현구 |
2021 | | Caveolin-1 deficiency impairs synaptic transmission in hippocampal neurons | 박상면 |
2019 | | Cholesterol Metabolism in the Brain and Its Association with Parkinson's Disease | 박상면 |
2020 | | Critical roles of astrocytic-CCL2-dependent monocyte infiltration in a DJ-1 knockout mouse model of delayed brain repair | 김병곤, 박상면, 이건아, 조은혜, 주일로 |
2023 | | Critical roles of parkin and PINK1 in coxsackievirus B3-induced viral myocarditis | 김수정, 박상면, 우현구, 조은혜, 진우람 |
2021 | | Dying neurons conduct repair processes in the injured brain through osteopontin expression in cooperation with infiltrated blood monocytes | 김병곤, 박상면, 조은혜, 주일로, 최용준 |
2024 | | GPR40 agonist ameliorates neurodegeneration and motor impairment by regulating NLRP3 inflammasome in Parkinson's disease animal models | 박상면 |
2024 | | Integration of National Health Insurance claims data and animal models reveals fexofenadine as a promising repurposed drug for Parkinson’s disease | 김동규, 김수정, 박상면, 우현구 |
2021 | | Interaction between coxsackievirus B3 infection and α-synuclein in models of Parkinson's disease | 박상면, 박수진, 진우람 |
2022 | | Interleukin-6 signaling requires EHD1-mediated alteration of membrane rafts | 박상면, 박수정, 조은혜 |
2021 | | Kir4.1 is coexpressed with stemness markers in activated astrocytes in the injured brain and a Kir4.1 inhibitor BaCl2 negatively regulates neurosphere formation in culture | 박상면, 양해걸, 조은혜, 주일로 |
2020 | | Molecular events underlying the cell-to-cell transmission of alpha-synuclein | 박상면, 박수진 |
2023 | | Monitoring α-synuclein Aggregation Induced by Preformed α-synuclein Fibrils in an In Vitro Model System | 박상면, 전형준 |
2021 | | Neural stem cells derived from human midbrain organoids as a stable source for treating Parkinson's disease: Midbrain organoid-NSCs (Og-NSC) as a stable source for PD treatment | 박상면 |
2022 | | Neuronal ApoE Regulates the Cell-to-Cell Transmission of α-Synuclein | 김수정, 박상면, 박선아, 진우람 |
2020 | | Region-specific astrogliosis: differential vessel formation contributes to different patterns of astrogliosis in the cortex and striatum | 박상면, 이기황, 조은혜, 주일로 |
2022 | | Sargachromenol Isolated from Sargassum horneri Attenuates Glutamate-Induced Neuronal Cell Death and Oxidative Stress through Inhibition of MAPK/NF-κB and Activation of Nrf2/HO-1 Signaling Pathway | 박상면 |
2024 | | Systemic inflammation attenuates the repair of damaged brains through reduced phagocytic activity of monocytes infiltrating the brain | AN, JIAWEI, 박상면, 양해걸, 이건아, 이은정, 조은혜 |
2020 | | The dual role of c-src in cell-to-cell transmission of alpha-synuclein | 박상면, 조은혜, 주일로, 최유리 |
2024 | | The LRRK2-G2019S mutation attenuates repair of brain injury partially by reducing the release of osteopontin-containing monocytic exosome-like vesicles | AN, JIAWEI, 박상면, 조은혜, 최용준 |
2022 | | Therapeutic functions of astrocytes to treat α-synuclein pathology in Parkinson's disease | 박상면 |